These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 34070277)
21. Recent Approaches and Strategies in the Generation of Anti-human Cytomegalovirus Vaccines. Boppana SB; Britt WJ Methods Mol Biol; 2021; 2244():403-463. PubMed ID: 33555597 [TBL] [Abstract][Full Text] [Related]
22. Prevention of Congenital Cytomegalovirus Infection with Vaccines: State of the Art. Esposito S; Chiopris G; Messina G; D'Alvano T; Perrone S; Principi N Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34069321 [TBL] [Abstract][Full Text] [Related]
23. Pre-existing immunity to cytomegalovirus in macaques influences human CMV vaccine responses in preclinical models. Webster H; Valencia S; Kumar A; Chan C; Dennis M; Roark H; Woods A; John S; Carfi A; Permar SR Vaccine; 2021 Sep; 39(38):5358-5367. PubMed ID: 34393017 [TBL] [Abstract][Full Text] [Related]
24. Inclusion of the Guinea Pig Cytomegalovirus Pentameric Complex in a Live Virus Vaccine Aids Efficacy against Congenital Infection but Is Not Essential for Improving Maternal and Neonatal Outcomes. Schleiss MR; Fernández-Alarcón C; Hernandez-Alvarado N; Wang JB; Geballe AP; McVoy MA Viruses; 2021 Nov; 13(12):. PubMed ID: 34960639 [TBL] [Abstract][Full Text] [Related]
25. DNA vaccine prime followed by boost with live attenuated virus significantly improves antigen-specific T cell responses against human cytomegalovirus. Gil A; Shen S; Coley S; Gibson L; Diamond DJ; Wang S; Lu S Hum Vaccin Immunother; 2013 Oct; 9(10):2120-32. PubMed ID: 24051429 [TBL] [Abstract][Full Text] [Related]
26. Recent approaches and strategies in the generation of antihuman cytomegalovirus vaccines. Boppana SB; Britt WJ Methods Mol Biol; 2014; 1119():311-48. PubMed ID: 24639230 [TBL] [Abstract][Full Text] [Related]
27. Vaccine strategies against human cytomegalovirus infection. Zhong J; Khanna R Expert Rev Anti Infect Ther; 2007 Jun; 5(3):449-59. PubMed ID: 17547509 [TBL] [Abstract][Full Text] [Related]
29. Maternal immune correlates of protection against placental transmission of cytomegalovirus. Itell HL; Nelson CS; Martinez DR; Permar SR Placenta; 2017 Dec; 60 Suppl 1(Suppl 1):S73-S79. PubMed ID: 28456432 [TBL] [Abstract][Full Text] [Related]
30. Progress on pursuit of human cytomegalovirus vaccines for prevention of congenital infection and disease. Fu TM; An Z; Wang D Vaccine; 2014 May; 32(22):2525-33. PubMed ID: 24681264 [TBL] [Abstract][Full Text] [Related]
31. Is HCMV vaccine an unmet need? The state of art of vaccine development. Chiurchiu S; Calo Carducci FI; Rocchi F; Simonetti A; Bonatti G; Salmaso S; Melchiorri D; Pani L; Rossi P Int J Immunopathol Pharmacol; 2013; 26(1):15-26. PubMed ID: 23527705 [TBL] [Abstract][Full Text] [Related]
32. VCL-CB01, an injectable bivalent plasmid DNA vaccine for potential protection against CMV disease and infection. Schleiss MR Curr Opin Mol Ther; 2009 Oct; 11(5):572-8. PubMed ID: 19806506 [TBL] [Abstract][Full Text] [Related]
33. Detection of congenital cytomegalovirus in newborns using nucleic acid amplification techniques and its public health implications. Liu G; Hai R; Liu F Virol Sin; 2017 Oct; 32(5):376-386. PubMed ID: 29116590 [TBL] [Abstract][Full Text] [Related]
34. Antiviral Treatment of Maternal and Congenital Cytomegalovirus (CMV) Infections. Pinninti S; Boppana S Viruses; 2023 Oct; 15(10):. PubMed ID: 37896892 [TBL] [Abstract][Full Text] [Related]
35. An Attenuated CMV Vaccine with a Deletion in Tegument Protein GP83 (pp65 Homolog) Protects against Placental Infection and Improves Pregnancy Outcome in a Guinea Pig Challenge Model. Schleiss MR; Buus R; Choi KY; McGregor A Future Virol; 2013 Dec; 8(12):1151-1160. PubMed ID: 24465269 [TBL] [Abstract][Full Text] [Related]
36. Cytomegalovirus DNA Detection by Polymerase Chain Reaction in Cerebrospinal Fluid of Infants With Congenital Infection: Associations With Clinical Evaluation at Birth and Implications for Follow-up. Goycochea-Valdivia WA; Baquero-Artigao F; Del Rosal T; Frick MA; Rojo P; Echeverría MJ; Noguera-Julian A; Bringué X; Saavedra-Lozano J; Vives-Oñós I; Moliner E; Cilleruelo MJ; Cuadrado I; Colino E; Castells L; Tagarro A; Vilas J; Soler-Palacin P; Blázquez-Gamero D; Clin Infect Dis; 2017 May; 64(10):1335-1342. PubMed ID: 28158709 [TBL] [Abstract][Full Text] [Related]
37. HCMV Infection Reduces Nidogen-1 Expression, Contributing to Impaired Neural Rosette Development in Brain Organoids. Ijezie EC; O'Dowd JM; Kuan MI; Faeth AR; Fortunato EA J Virol; 2023 May; 97(5):e0171822. PubMed ID: 37125912 [TBL] [Abstract][Full Text] [Related]
38. Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex. Ha S; Li F; Troutman MC; Freed DC; Tang A; Loughney JW; Wang D; Wang IM; Vlasak J; Nickle DC; Rustandi RR; Hamm M; DePhillips PA; Zhang N; McLellan JS; Zhu H; Adler SP; McVoy MA; An Z; Fu TM J Virol; 2017 Apr; 91(7):. PubMed ID: 28077654 [TBL] [Abstract][Full Text] [Related]
39. Efficient Delivery of Human Cytomegalovirus T Cell Antigens by Attenuated Sendai Virus Vectors. Kiener R; Fleischmann M; Wiegand MA; Lemmermann NAW; Schwegler C; Kaufmann C; Renzaho A; Thomas S; Felder E; Niller HH; Asbach B; Wagner R J Virol; 2018 Aug; 92(15):. PubMed ID: 29769344 [TBL] [Abstract][Full Text] [Related]
40. Vaccine Development for Cytomegalovirus. Inoue N; Abe M; Kobayashi R; Yamada S Adv Exp Med Biol; 2018; 1045():271-296. PubMed ID: 29896672 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]